Survival and medical costs of non-small cell lung cancer patients according to the first-line treatment: An observational study using the Kyoto City Integrated Database.
Tomonari ShimamotoYukiko TateyamaDaisuke KobayashiKeiichi YamamotoYoshimitsu TakahashiHiroaki UeshimaKosuke SasakiTakeo NakayamaTaku IwamiPublished in: Thoracic cancer (2023)
As a first-line therapy in newly diagnosed patients with NSCLC, surgical resection is associated with longer survival and lower medical costs than pharmacotherapy or radiotherapy.
Keyphrases
- newly diagnosed
- healthcare
- end stage renal disease
- small cell lung cancer
- ejection fraction
- chronic kidney disease
- early stage
- emergency department
- prognostic factors
- squamous cell carcinoma
- radiation therapy
- free survival
- stem cells
- radiation induced
- advanced non small cell lung cancer
- cell therapy
- patient reported
- adverse drug